Login

Consolidated balance sheets

In millions of USD, except per-share amounts
Q2 FY2023
As of Jun 30, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
Q2 FY2021
As of Jun 30, 2021
Q1 FY2021
As of Mar 31, 2021
Q4 FY2020
As of Dec 31, 2020
Q3 FY2020
As of Sep 30, 2020
Q2 FY2020
As of Jun 30, 2020
Q1 FY2020
As of Mar 31, 2020
Q4 FY2019
As of Dec 31, 2019
Q3 FY2019
As of Sep 30, 2019
Q2 FY2019
As of Jun 30, 2019
Q1 FY2019
As of Mar 31, 2019
Q4 FY2018
As of Dec 31, 2018
Q3 FY2018
As of Sep 30, 2018
Q2 FY2018
As of Jun 30, 2018
CURRENT ASSETS:
Cash And Cash Equivalents
Cash and cash equivalents
Accounts receivable
Other Receivables
Inventory
Advances
Deposits
Current assets of discontinued operations
Inventory, net
Total current assets
Property and equipment, net
Intangible assets, net
Goodwill
Other receivables from related parties
Long term assets of discontinued operations
Fixed assets, net of accumulated depreciation
Operating lease right of use asset
TOTAL ASSETS
Accounts payable
Accrued expenses
Notes payable- PPP/EIDL loans, current
Accrued Expenses - Related Parties
Deferred revenue
Due on asset purchase
Notes payable- PPP/EIDL loans
Note payable to bank
Notes payable, net
Long term acquisition of EZ-CLONE Enterprises, Inc. payable in common stock
Notes  payable
Convertible notes payable, in default net
Notes Payable- Related Party
Acquisition of EZ-CLONE Enterprises, Inc. payable in cash
Acquisition of EZ-CLONE Enterprises, Inc. payable in common stock
Current portion of operating lease right of use liability
Federal and state income taxes payable
Convertible notes payable, net
Derivative liability
Current liabilities of discontinued operations
Operating lease right of use liability
Total current liabilities
Deferred tax liability
Non-current portion of operating lease right of use liability
Long term liabilities of discontinued operations
Total long term liabilities
Commitments And Contingencies
Series A Preferred stock - $0.0001 par value, 10,000,000 shares authorized, 600 shares and 1,800 shares issued and outstanding at 6/30/2023 and 12/31/2022, respectively
Series A Preferred Stock
Total series A Preferred stock - $0.0001 par value, 10,000,000 shares authorized, 600 shares and 1,800 shares issued and outstanding at 6/30/2023 and 12/31/2022, respectively
Common stock - $0.0001 par value, 740,000,000 shares authorized, 35,561,190 and 7,083,254 shares issued and outstanding at 6/30/2023 and 12/31/2022 , respectively
Additional paid in capital
Accumulated deficit
Total stockholders' deficit
TOTAL LIABILITIES AND  STOCKHOLDERS' DEFICIT

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support